drugset / Trial / NCT04587219
The Study of "Gam-COVID-Vac" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older
Phase 2
Unknown
110 enrolled
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study: to assess the safety, tolerability and immunogenicity of the drug "Gam-COVID-Vac", a solution for intramuscular injection, at various times after vaccination in volunteers over 60 years of age
Timeline
- Start
- 2020-10-22
- Primary completion
- 2021-03-30
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gam-COVID-Vac | Vaccine | 0.5 ml | Intramuscular |